NCT01117766View on ClinicalTrials.gov

Study To Assess The Reproducibility And Sensitivity Of Quantitative Sensory Testing In Patients With Neuropathic Pain

NACompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

December 31, 2006

Primary Completion Date

September 30, 2009

Study Completion Date

September 30, 2009

Conditions
Neuropathic Pain
Interventions
DRUG

Pregabalin

Dose titration according to following regimen: 75mg BID for 3 days; 150mg for 4 days; 225mg BID for 4 days; 300mg BID for 17 days. Dose reduced for renally impaired patients

DRUG

Placebo

BID dosing for 28 days

Trial Locations (5)

1070

Pfizer Investigational Site, Brussels

92100

Pfizer Investigational Site, Boulogne-Billancourt

A-1090

Pfizer Investigational Site, Vienna

L9 7AL

Pfizer Investigational Site, Liverpool

SW10 9NH

Pfizer Investigational Site, London

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT01117766 - Study To Assess The Reproducibility And Sensitivity Of Quantitative Sensory Testing In Patients With Neuropathic Pain | Biotech Hunter | Biotech Hunter